logo

For the Inventor, By the Inventor

Lyon, France

Manuel Rosa-Calatrava

This inventor holds 10 USPTO granted patents, plus 2 CIPO patents. Top assignees: Centre National De La Recherche Scientifique, University Claude Bernard - Lyon 1, Hospices Civils De Lyon. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manuel Rosa-Calatrava. Retrieved from https://idiyas.com/inventor/manuel-rosa-calatrava

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 60.0

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:

goldMedal7 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
silverMedal7 out of 215 
 
University Claude Bernard - Lyon 1
 patents
bronzeMedal6 out of 46 
 
Hospices Civils De Lyon
 patents
4. 6 out of 1,853 
 
National Institute of Health and Medical Research
 patents
5. 5 out of 304 
 
Universitè Laval
 patents
6. 3 out of 44 
 
Ecole Normale Superieure De Lyon
 patents
7. 1 out of 2 
 
Calixar
 patents
8. 1 out of 16 
 
Institut National De La Santé Et De La Recherche Médicale (Inserm)
 patents
9. 1 out of 1 
 
Université Claud Bernard Lyon 1
 patent
10. 1 out of 18 
 
Universite Claude Bernard Lyon 1
 patents
11. 1 out of 50 
 
University Claude Bernard Lyon I
 patents
12. 1 out of 108 
 
University of Dundee
 patents
where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12594280 - Antiviral compositions for treating the flu (2026-04-07),
2. 12440498 - Combination of diltiazem and viral polymerase inhibitors (2025-10-14),
3. 12285433 - Diltiazem for use in the treatment of microbial infections (2025-04-29),
4. 11510896 - Antiviral compositions for the treatment of infections linked to coronaviruses (2022-11-29),
5. 11504424 - Attenuated virus strain and use thereof as a vaccine (2022-11-22),
6. 11351180 - Antiviral compositions for treating the flu (2022-06-07),
7. 10144917 - Method for preparing a vaccine antigen, resulting vaccine antigen and uses (2018-12-04),
8. 9433592 - Pharmaceutical or veterinary antiviral compositions (2016-09-06),
9. 9381238 - Method for improving the production of influenza viruses and vaccine seeds (2016-07-05),
10. 8956626 - Modified viral strains and method for improving the production of vaccine seeds of influenza virus (2015-02-17),

Title: The Innovative Mind of Manuel Rosa-Calatrava

Introduction: Manuel Rosa-Calatrava, a visionary inventor based in Lyons, France, is renowned for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Manuel Rosa-Calatrava holds several patents in the areas of renewable energy systems, sustainable architecture, and advanced transportation solutions.

Career Highlights: With a career spanning over two decades, Manuel Rosa-Calatrava has been at the forefront of developing cutting-edge technologies that have revolutionized various industries. His work has been instrumental in shaping the future of sustainable living and transportation.

Collaborations: Throughout his career, Manuel Rosa-Calatrava has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His collaborative efforts have resulted in the successful implementation of several groundbreaking projects.

Conclusion: Manuel Rosa-Calatrava's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…